Literature DB >> 3808993

Pulmonary arterial changes in patients with ventricular septal defects and severe pulmonary hypertension.

R Fried, G Falkovsky, J Newburger, A I Gorchakova, M Rabinovitch, M I Gordonova, D Fyler, L Reid, V Burakovsky.   

Abstract

In 25 patients, aged eight months to 31 years, with ventricular septal defect (VSD; isolated in 15, the others with atrial septal defect, PDA, coarctation or patent ductus arteriosus + coarctation), each with severe pulmonary artery hypertension (pulmonary artery systolic pressure [Ppa] at least 75% of systemic and an elevated pulmonary vascular resistance), we related morphologic and morphometric data from open-lung biopsy to hemodynamic measurements obtained at cardiac catheterization during the same hospital admission. Of the hemodynamic features measured, only the ratios of pulmonary-to-systemic flow and pulmonary-to-systemic resistance correlated significantly with structure. Neither pulmonary artery pressure (Ppa) nor pulmonary vascular resistance correlated significantly with any structural feature studied. The increased external diameter of respiratory bronchiolar arteries in those with the more advanced Heath-Edwards grades reflects dilatation and suggests that it is in the small arteries of the distal arterial bed that the changes of pulmonary hypertension are most significant. Neither age nor body weight correlated significantly with the degree of structural or hemodynamic abnormality. In the ten patients who underwent VSD closure, Ppa was measured postoperatively. The Heath-Edwards grade (no more than one grade-III lesion) and arterial density (at least one-half that normal for age) were the best correlates of the difference between preoperative Ppa and Ppa immediately after corrective surgery. The presurgical catheterization data, including pulmonary resistance and the resistance ratio, did not correlate significantly with change in Ppa following VSD closure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3808993     DOI: 10.1007/BF02424988

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  26 in total

1.  THE PATHOGENESIS OF VASCULAR LESIONS IN EXPERIMENTAL HYPERKINETIC PULMONARY HYPERTENSION.

Authors:  S E DOWNING; R A VIDONE; H M BRANDT; A A LIEBOW
Journal:  Am J Pathol       Date:  1963-11       Impact factor: 4.307

2.  Wall shear stress distribution in a model canine artery during steady flow.

Authors:  R J Lutz; J N Cannon; K B Bischoff; R L Dedrick; R K Stiles; D L Fry
Journal:  Circ Res       Date:  1977-09       Impact factor: 17.367

3.  Postoperative assessment of patients with ventricular septal defect and pulmonary hypertension. Response to intense upright exercise.

Authors:  B J Maron; D R Redwood; J W Hirshfeld; R E Goldstein; A G Morrow; S E Epstein
Journal:  Circulation       Date:  1973-10       Impact factor: 29.690

Review 4.  Quantitative structural analysis of the pulmonary vascular bed in congenital heart defects.

Authors:  M Rabinovitch; L M Reid
Journal:  Cardiovasc Clin       Date:  1981

5.  The effect of local blood flow patterns on endothelial cell morphology.

Authors:  M A Reidy; B L Langille
Journal:  Exp Mol Pathol       Date:  1980-06       Impact factor: 3.362

6.  Development of the pulmonary circulation in ventricular septal defect: a quantitative structural study.

Authors:  S G Haworth; U Sauer; K Bũhlmeyer; L Reid
Journal:  Am J Cardiol       Date:  1977-11       Impact factor: 2.778

7.  Quantitative structural analysis of pulmonary vessels in isolated ventricular septal defect in infancy.

Authors:  A Hislop; S G Haworth; E A Shinebourne; L Reid
Journal:  Br Heart J       Date:  1975-10

8.  Lung biopsy with frozen section as a diagnostic aid in patients with congenital heart defects.

Authors:  M Rabinovitch; A R Castaneda; L Reid
Journal:  Am J Cardiol       Date:  1981-01       Impact factor: 2.778

9.  Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects.

Authors:  M Rabinovitch; J F Keane; W I Norwood; A R Castaneda; L Reid
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

10.  Early pulmonary vascular changes in congenital heart disease studied in biopsy tissue.

Authors:  M Rabinovitch; S G Haworth; Z Vance; G Vawter; A R Castaneda; A S Nadas; L M Reid
Journal:  Hum Pathol       Date:  1980-09       Impact factor: 3.466

View more
  6 in total

1.  Lung function in VSD patients after corrective heart surgery.

Authors:  J Sulc; M Samánek; A Zapletal; M Vorísková; B Hucín; J Skovránek
Journal:  Pediatr Cardiol       Date:  1996 Jan-Feb       Impact factor: 1.655

2.  Do preoperative haemodynamic data and reactivity test predict the postoperative reversibility of pulmonary arterial hypertension in patients with large ventricular septal defect and borderline operability?

Authors:  Anuradha Sridhar; Raghavan Subramanyan; Nithya Lakshmi; Farida Farzana; Ravi Ranjan Tripathi; Rajasekaran Premsekar; Shanthi Chidambaram Pillai; Soman Rema Krishna Manohar; Ravi Agarwal; Kotturathu Mammen Cherian
Journal:  Heart Asia       Date:  2013-08-21

3.  Implication of in vivo circulating fibrocytes ablation in experimental pulmonary hypertension murine model.

Authors:  Vandana S Nikam; Sandeep Nikam; Akyl Sydykov; Katrin Ahlbrecht; Rory E Morty; Werner Seeger; Robert Voswinckel
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

4.  Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease.

Authors:  A Bush; C M Busst; S G Haworth; A A Hislop; W B Knight; B Corrin; E A Shinebourne
Journal:  Br Heart J       Date:  1988-04

5.  A process-based review of mouse models of pulmonary hypertension.

Authors:  Mita Das; Joshua Fessel; Haiyang Tang; James West
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

6.  Pulmonary arterial remodeling induced by a Th2 immune response.

Authors:  Eleen Daley; Claire Emson; Christophe Guignabert; Rene de Waal Malefyt; Jennifer Louten; Viswanath P Kurup; Cory Hogaboam; Laimute Taraseviciene-Stewart; Norbert F Voelkel; Marlene Rabinovitch; Ekkehard Grunig; Gabriele Grunig
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.